文献速递其他结缔组织病

EULAR/ACR特发性炎性肌病分类标准在日本儿童队列中的外部验证

External validation of the EULAR/ACR idiopathic inflammatory myopathies classification criteria with a Japanese paediatric cohort.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

本研究在日本7个儿童风湿病中心纳入68例青少年特发性炎性肌病(JIIM)患者和49例非JIIM患者,回顾性验证EULAR/ACR分类标准的性能。结果显示该标准总体敏感度89.7%、特异度100%,优于Bohan和Peter标准(敏感度80.9%)及Tanimoto标准(敏感度64.7%)。7例未达分类阈值(55%)的JIIM患者中3例幼年皮肌炎仅表现Gottron征。

要点

  • EULAR/ACR标准在日本JIIM队列中敏感度89.7%、特异度100%。
  • 有肌肉活检数据时敏感度92.1%,无活检数据时敏感度86.7%。
  • 7例未分类患者中3例幼年皮肌炎仅表现Gottron征。

核心结论

  • EULAR/ACR特发性炎性肌病分类标准在日本JIIM病例中总体性能优于现有肌炎诊断标准。

研究设计与样本

  • 回顾性纳入2008至2015年日本7个儿童风湿病中心的68例JIIM患者和49例非JIIM患者,由专家组复核诊断后应用EULAR/ACR标准并计算概率。

主要发现

  • EULAR/ACR标准在总队列(n=68)的敏感度/特异度为89.7%/100%。
  • 有肌肉活检数据者(n=38)敏感度/特异度为92.1%/100%,无活检数据者(n=30)为86.7%/100%。
  • Bohan和Peter标准及Tanimoto标准在总队列的敏感度分别为80.9%和64.7%。
  • 68例临床诊断JIIM中7例(3例幼年皮肌炎、4例重叠肌炎)因概率未达55%阈值而未被分类。
  • 3例未分类的幼年皮肌炎均仅表现Gottron征这一种皮肤表现。

关键数值与推荐

  • EULAR/ACR分类标准概率阈值为55%。
  • 总队列敏感度89.7%、特异度100%;有活检亚组敏感度92.1%、特异度100%;无活检亚组敏感度86.7%、特异度100%。
  • Bohan和Peter标准敏感度80.9%,Tanimoto标准敏感度64.7%。

临床怎么用

  • 在亚洲儿童JIIM人群中可优先使用EULAR/ACR分类标准,其敏感度和特异度均较高。
  • 对于仅表现Gottron征的幼年皮肌炎患者,需注意EULAR/ACR标准可能因概率未达55%而漏分类。

局限性

  • 回顾性研究设计,样本量较小(68例JIIM和49例非JIIM),仅来自日本7个中心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the performance of the EULAR/ACR idiopathic inflammatory myopathies (IIMs) classification criteria to classify juvenile IIMs (JIIMs) in an Asian paediatric population. METHODS: Sixty-eight JIIM patients and 49 non-JIIM patients diagnosed at seven major paediatric rheumatology centres in Japan between 2008 and 2015 were enrolled. Retrospective data were collected, and each patient's data form was submitted. The expert group reviewed the forms and re-examined the diagnoses. The EULAR/ACR criteria were then applied and the probability of having JIIM was determined for each case. The sensitivity and specificity of the EULAR/ACR criteria were compared with those of other existing criteria. RESULTS: The sensitivity/specificity of the EULAR/ACR classification criteria were 92.1/100% with muscle biopsy data (n = 38); 86.7/100% without muscle biopsy data (n = 30) and 89.7/100% in our total cohort (n = 68). The sensitivity of Bohan and Peter's criteria and Tanimoto's criteria were 80.9 and 64.7% in our total cohort, respectively. Among 68 physician-diagnosed JIIM patients, seven cases (three JDM and four overlap myositis) were not classified as JIIM because the probability did not reach the cut-off point (55%). The three JDM patients all presented with only one of the three skin manifestations that are listed in the criteria: Gottron's sign. CONCLUSION: Our validation study with Japanese JIIM cases indicates that the EULAR/ACR classification criteria for IIM generally perform better than existing diagnostic criteria for myositis.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Yamazaki K, Ohta A, Akioka S, et al. External validation of the EULAR/ACR idiopathic inflammatory myopathies classification criteria with a Japanese paediatric cohort. Rheumatology (Oxford). 2021. PMID: 32810274. doi:10.1093/rheumatology/keaa274

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。